Paracrine transfer of mouse mammary tumor virus superantigen

Journal of Experimental Medicine

Volumn 185, Issue 3, 1997, Pages 471-480

  Delcourt, Marc ^a   Thibodeau, Jacques ^b   Denis, Francois ^a   Sekaly, Rafick Pierre ^a,c,d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; HLA DR ANTIGEN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL CONTACT; CELL TRANSFER; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE LOCUS; HYBRIDOMA; INTRACELLULAR TRANSPORT; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL COMMUNICATION; CELL LINE; ENTEROTOXINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED CBA; SUPERANTIGENS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0031054243     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.3.471     Document Type: Article

References (51)

1. Kappler, J.W., B. Kotzin, L. Herron, E.W. Gelfand, R.D. Bigler, A. Boylston, S. Carrel, D.N. Posnett, Y. Choi, and P. Marrack. 1989. V beta-specific Stimulation of human T cells by staphylococcal toxins. Science (Wash. DC). 244:811-813.
2. Tomai, M.A., J.A. Aelion, M.E. Dockter, G. Majumdar, D.G. Spinella, and M. Kotb. 1991. T cell receptor V gene usage by human T cells stimulated with the superantigen streptococcal M protein. J. Exp. Med. 174:285-292.
3. Tomai, M., M. Kotb, G. Majumdar, and E.H. Beachey. 1990. Superantigenicity of streptococcal M protein. J. Exp. Med. 172:359-362.
4. MacDonald, H.R., R. Schneider, R.K. Lees, R.C. Howe, H. Acha-Orbea, H. Festenstein, R.M. Zinkernagel, and H. Hengartner. 1988. T-cell receptor V beta use predicts reactivity and tolerance to Mlsa-encoded antigens. Nature (Lond.). 332:40-45.
5. Kappler, J.W., U. Staerz, J. White, and P.C. Marrack. 1988. Self-tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature (Lond.). 332:35-40.
6. Lafon, M., M. Lafage, A. Martinez-Arends, R. Ramirez, F. Vuillier, D. Charron, V. Lotteau, and D. Scott-Algara. 1992. Evidence for a viral superantigen in humans, Nature (Lond.). 358:507-510.
7. Held, W., G.A. Waanders, A.N. Shakhov, L. Scarpellino, H. Acha-Orbea, and H.R. MacDonald. 1993. Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell. 74:529-540.
8. Golovkina, T.V., A. Chervonsky, J.P. Dudley, and S.R. P. oss. 1992. Transgenic mouse mammary tumor virus super-antigen expression prevents viral infection. Cell. 69:637-645.
9. Golovkina, T.V., J.P. Dudley, A.B. Jaffe, and S.R. Ross. 1995. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection, Proc. Natl. Acad. Sci. USA. 92:4828-4832.
10. Astoul, E., M. Lafage, and M. Lafon. 1996. Rabies superantigen as a V-beta T-dependent adjuvant. J. Exp. Med. 183: 1623-1631.
11. Kozak, C., G. Peters, R. Pauley, V. Morris, R. Michalides, J. Dudley, M. Green, M. Davisson, O. Prakash, and A. Vaidya. 1987. A standardized nomenclature for endogenous mouse mammary tumor viruses. J. Virol. 61:1651-1654.
12. Simpson, E. 1993. T cell repertoire selection by mouse mammary tumour viruses. Eur.J. Immunogenetics. 20:137-149.
13. Choi, Y., J.W. Kappler, and P. Marrack. 1991. A superantigen encoded in the open reading trame of the 3′ long terminal repeat of mouse mammary tumour virus, Nature (Lond.). 350:203-209.
14. Acha-Orbea, H., A.N. Shakhov, L. Scarpellino, E. Kolb, V. Muller, A. Vessaz-Shaw, R. Fuchs, K. Blochlinger, P. Rollini, and J. Billotte. 1991. Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumour virus. Nature (Lond.). 350:207-217.
15. Beutner, U., W.N. Frankel, M.S. Cote, J.M. Coffin, and B.T. Huber. 1992. Mis-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc. Natl. Acad. Sci. USA. 89:5432-5436.
16. Korman, A.J., P. Bourgarel, T. Meo, and G.E. Rieckhof. 1992. The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO (Eur. Mol. Biol. Organ.) J. 11:1901-1905.
17. Choi, Y., P. Marrack, and J.W. Kappler. 1992. Structural analysis of a mouse mammary tumor virus superantigen. J. Exp. Med. 175:847-852.
18. Yazdanbakhsh, K., C.G. Park, G.M. Winslow, and Y. Choi. 1993. Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor V beta specificity. J. Exp. Med. 178:737-741.
19. Held, W., A.N. Shakhov, G. Waanders, L. Scarpellino, R. Luethy, J.P. Kraehenbuhl, H.R. MacDonald, and H. AchaOrbea. 1992. An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J. Exp. Med. 175:1623-1633.
20. Rudy, C.K., E. Kraus, E. Palmer, and B.T. Huber. 1992. Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7. J. Exp. Med. 175:1613-1621.
21. Pullen, A.M., Y. Choi, E. Kushnir, J.W. Kappler, and P.C. Marrack. 1992. The open reading frames in the 3′ long terminal repeats of several mouse mammary tumor virus integrants encode V beta 3-specific superantigens. J. Exp. Med. 175:41-47.
22. Happ, M.P., D.L. Woodland, and E. Palmer. 1989. A third T-cell receptor beta-chain variable region gene encodes reactivity to Mls-1a gene products. Proc. Natl. Acad. Sci. USA. 86:6293-6296.
23. Marrack, P., M. Blackman, E. Kushmr, and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 171:455-464.
24. Katz, M.E., and C.A. Janeway, Jr. 1985. The immunobiology of T cell responses to Mls-locus-disparate stimulator cells. II. Effects of Mls-locus-disparate stimulator cells on cloned, protein antigen-specific, Ia-restricted T cell lines. J. Immunol. 134:2064-2070.
25. MacDonald, H.R., A.L. Glasebrook, R. Schneider, R.K. Lees, H. Pircher, T. Pedrazzini, O. Kanagawa, J.F. Nicolas, R.C. Howe, and R.M. Zinkernagel. 1989. T-cell reactivity and tolerance to Mlsa-encoded antigens. Immunol. Rev. 107: 89-108.
26. Bill, J., O. Kanagawa, D.L. Woodland, and E. Palmer. 1989. The MHC molecule I-E is necessary but not sufficient for the clonal deletion of V beta 11-bearing T cells. J. Exp. Med. 169:1405-1419.
27. Okada, C.Y., and I.L. Weissman. 1989. Relative V beta transcript levels in thymus and peripheral lymphoid tissues from various mouse strains. Inverse correlation of I-E and MIs expression with relative abundance of several V beta transcripts in peripheral lymphoid tissues. J. Exp. MM. 169:1703-1719.
28. Labrecque, N., H. McGrath, M. Subramanyam, B.T. Huber, and R.P. Sekaly. 1993. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features. J. Exp. Med. 177: 1735-1743.
29. Subramanyam, M., B. McLellan, N. Labrecque, R.P. Sekaly, and B.T. Huber. 1993. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J. Immunol. 151:2538-2545.
30. DeKruyff, R.H., S.T. Ju, J. Laning, H. Cantor, and M.E. Dorf. 1986. Activation requirements of cloned inducer T cells. III. Need for two stimulator cells in the response of a cloned line to Mls determinants. J. Immunol. 137:1109-1114.
31. Speiser, D.E., R. Schneider, H. Hengartner, and H.R. Mac-Donald. 1989. Clonal deletion of self-reactive T cells in irradiation bone marrow chimeras and neonatally tolerant mice. Evidence for intercellular transfer of Mlsa. J. Exp. Med. 170: 595-600.
32. + T cells. Science (Wash. DC). 248:1643-1648.
33. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1249-1256.
34. Jacobson, S., R.P. Sekaly, C.L. Jacobson, H.F. McFarland, and E.O. Long. 1989. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J. Virol. 63:1756-1762.
35. Ausubel, F.M., R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl. 1995. Current protocols in immunology. J.A. Molecular Cloning. Wiley Interscience, editor. 201-203.
36. Acha-Orbea, H., L. Scarpellino, A.N. Shakhov, W. Held, and H.R. MacDonald. 1992. Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading trame protein. J. Exp. Med. 176:1769-1772.
37. Graham, F.L., and A.J. Van der Eb. 1973. Transformation of rat cells by DNA of human adenovirus 5. Virology. 54:536-539.
38. Gunning, P., J. Leavitt, G. Muscat, S.Y. Ng, and L. Kedes. 1987. A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA. 84:4831-4835.
39. Mamatis, T., E.F. Fritsch, and J. Sambrook. 1982. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
40. Bond, J.F., and S.R. Farmer. 1983. Regulation of tubulin and actin mRNA production in rat brain: expression of a new beta-tubulin mRNA with development. Mol. & Cell. Biol. 3: 1333-1342.
41. Landegren, U. 1984. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J. Immunol. Method. 67:379-388.
42. 41a. Thibodeau, J., M. Dohlsten, I. Cloutier, P.M. Lavoie, P. Bjork, F. Michel, C. Léveillé, W. Mourad, I. Kalland, and R.P. Sékaly. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to HLA-DRα chain. J. Immunol. In press.
43. Abrahmsen, L., M. Dohlsten, S. Segren, P. Bjork, E. Jonsson, and T. Kalland. 1995. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO (Eur. Mol. Biol Organ.) J. 14:2978-2986.
44. Kim, J., R.G. Urban, J.L. Strominger, and D.C. Wiley. 1994. Toxic shock syndrome toxin-1 complexed with a class II mafor histocompatibility molecule HLA-DR1. Science (Wash. DC). 266:1870-1874.
45. Thibodeau, J., I. Cloutier, P.M. Lavoie, N. Labrecque, W. Mourad, T. Jardetzky, and R.P. Sekaly. 1994. Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding. Science (Wash. DC). 266:1874-1878.
46. Winslow, G.M., M.T. Scherer, J.W. Kappler, and P. Marrack. 1992. Detection and biochemical characterization of the mouse mammary tumor virus 7 superantigen (Mls-1a). Cell. 71:719-730.
47. McCune, J.M., L.B. Rabin, M.B. Feinberg, M. Lieberman, J.C. Kosek, G.R. Reyes, and I.L. Weissman. 1988. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell. 53:55-67.
48. Jarvis, C.D., R.N. Germain, G.L. Hager, M. Damschroder, and L. A. Maris. 1994. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens. J. Immunol. 152:1032-1038.
49. Torres, B.A., N.D. Griggs, and H.M. Johnson. 1993. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens, Nature (Lond.). 364:152-154.
50. Moore, N.C., G. Anderson, D.E. McLoughlin, J.J. Owen, and E.J. Jenkinson. 1994. Differential expression of Mtv loci in MHC class II-positive thymic stromal cells. J. Immunol. 152:4826-4831.
51. Kaiserlian, D., K. Vidal, H.R. MacDonald, and I. Grosjean. 1993. Mouse intestinal epithelial cells express the self superantigen Mls1a. Eur. J. Immunol. 23:2717-2720.